AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 11 min read$MDLN

BCP 8 Holdings Mozart Manager L.L.C. (SCHWARZMAN STEPHEN A) sold $1.2B of MDLN (indirect holdings)

BCP 8 Holdings Mozart Manager L.L.C. sold 33,317,824 indirectly-held shares of Medline Inc. (MDLN) at $36.54 ($1.22B total) across 4 trades on 2026-05-28. Filed jointly with BMA VIII L.L.C. (10% owner), Blackstone Holdings II L.P. (10% owner), Blackstone Holdings I/II GP L.L.C. (10% owner), Blackstone Inc. (10% owner), Blackstone Group Management L.L.C. (10% owner) and SCHWARZMAN STEPHEN A (10% owner).

Original reporting
SEC EDGAR · BCP 8 Holdings Mozart Manager L.L.C., BMA VIII L.L.C., Blackstone Holdings II L.P., Blackstone Holdings I/II GP L.L.C., Blackstone Inc., Blackstone Group Management L.L.C., SCHWARZMAN STEPHEN A
Published Jun 1, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:47 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$MDLN
Bearish
high confidence
Mentioned
$MDLN
Relevance
9/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MDLNBearishMed
01

Why it matters

The disclosed sale reduces insider confidence and may trigger short‑term price weakness.

02

Market read

First‑report insider sale of over $1 B, material for traders monitoring MDLN.

03

What to watch

Potential tax planning or liquidity needs for the selling entities.

Relevance 9/10Novelty 8/10Timing: after-hours filing

Background

SEC Form 4 filing by BCP 8 Holdings Mozart Manager L.L.C. reporting an insider sale.

Company-level read

Ticker impact

$MDLNBearishHigh confidence
Context

Form 4 disclosed a $1.2 B open‑market sale of 33.3 M shares, reducing insider ownership to 1,539 shares.

Expected impact

likely downward pressure as the market absorbs the sizable sale.

Evidence & confidence

The transaction size ($1.2 B) and reduction of insider stake are material and newly reported.

Market effects

Sector

May raise concerns for the medical supplies sector if insiders are exiting.

Regional

Limited to U.S. markets where MDLN trades.

Global

Minimal global impact beyond sector peers.

Counterpoint

What could challenge this read

The sale could be a portfolio rebalancing unrelated to company fundamentals.

Key entities

  • Company
    Medline Inc.

    Issuer of the shares sold.

  • Insider
    BCP 8 Holdings Mozart Manager L.L.C.

    Reporting entity and 10% owner.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

MDLN insider trading history →

Related articles

AUG 28
$MDLNMed

Medline rises as investors weigh new customer wins and post-earnings reset

Medline Inc. (MDLN) shares rose 3.2% after announcing new customer wins, including expanded agreements with Stillwater Medical Center and Ohio County Healthcare. The company reported 11.6% sales growth in Q2 but lowered full-year EBITDA guidance. Analysts have mixed price targets, with a median of $53.0. Insider trading shows mostly sales, while hedge funds have varied positions.

quiverquant.com2 min
AUG 14
Med

Medline Adds Customers, Distribution Capacity as Sales Rise 11.6%

Medline reported Q2 sales up 11.6% to $7.685B and net income down 58.3% to $139M, citing $336M fire-related losses tied to its Tracy, California distribution center. For 1H 2026, sales rose 11.1% to $15.037B. Medline said it signed over $650M in new customer business and is adding distribution centers, automation, and workers, including California capacity expansion to about 5M sq ft by mid-2027.

distributionstrategy.com6 min
AUG 14
$MDLNMed

Medline (MDLN) Q2 2026 Earnings Call Transcript

Medline (MDLN) Q2 2026 call said adjusted EBITDA rose 13% YoY to $1.1B, with higher costs partly offset by a $243M IEEPA tariff refund benefit. Q2 net sales grew 12% to $7.7B. Company raised fiscal 2026 organic sales outlook, but moderated adjusted EBITDA outlook citing Middle East conflict, Tracy warehouse fire, investments, quality remediation, and retail softness.

yahoo.com7 min
AUG 13
$MDLNMed

Medline Convenience Kits Impacted By Contamination In Recalled Becton Dickinson Products - Medline (NASDA

Medline said regulatory guidance followed its corrective actions for surgical convenience kits whose components were affected by a Becton Dickinson recall. The alert cites BD lot 4032183 ChloraPrep Clear 1 mL and lot 4073005 FREPP Clear 1.5 mL applicators, with compromised sterile seals and possible Aspergillus contamination. Medline reported no severe injuries or deaths as of Aug 3. MDLN shares were $35.71, up 0.61%.

benzinga.com4 min